RNAi Technology Market Growth, Trends & Forecast | Leading RNA Interference Solutions in 2025 | Top key players - Novartis AG, AstraZeneca, Silence Therapeutics | US Tariff Influence

The Global RNAi Technology Market reached US$ 1.6 billion in 2022 and is expected to reach US$ 3.6 billion by 2031 growing with a CAGR of 10.3% during the forecast period 2024-2031.

RNAi Technology Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Request a Free Sample PDF of This Report (Corporate Email IDs Receive Priority Service): https://datamintelligence.com/download-sample/rnai-technology-market?sz

RNA interference (RNAi) technology involves the use of small RNA molecules to silence specific genes, preventing their expression. This innovative technology has revolutionized genetic research and holds potential for treating various diseases, including cancers, viral infections, and genetic disorders. By targeting and regulating gene expression, RNAi offers a promising avenue for developing new therapeutic treatments and personalized medicine.

List of the Key Players in the RNAi Technology Market:

Alnylam Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., Atalanta Therapeutics, Phio Pharmaceuticals, Benitec Biopharma, Novartis AG, AstraZeneca, Silence Therapeutics, Arbutus Biopharma, and Sylentis S.A. among others.

Industry Development:

On May 18, 2023, Phio Pharmaceuticals Corp., a biotechnology company at the development stage, shared exciting pre-clinical data. The data demonstrated that using INTASYL to silence CBL-B and TIGIT could boost the anti-tumor response of NK cells, leading to more effective cell therapy for cancer treatment. Phio's proprietary INTASYL RNAi platform has been designed to improve the ability of immune cells to target and eliminate tumor cells, potentially offering a powerful new approach to cancer therapy.

In a significant step forward in the fight against neurodegenerative diseases, on April 26, 2023, Regeneron Pharmaceuticals, Inc. and Alnylam Pharmaceuticals, Inc. released encouraging preliminary results from the ongoing Phase 1 study of ALN-APP, an investigational RNAi therapy. This innovative therapy targets the amyloid precursor protein (APP) and is being developed to treat cerebral amyloid angiopathy (CAA) and Alzheimer's disease. Early findings from the single ascending dose portion of the trial show promise, offering hope for new treatment options for these devastating conditions.

Assessing the Effects of U.S. Tariffs on the Market

The U.S. tariff war is reshaping how businesses analyze trends and make strategic decisions. As tariffs drive up costs and disrupt supply chains, companies are increasingly focused on understanding consumer behavior, identifying new sourcing opportunities, and adjusting their operations to remain competitive. The ongoing uncertainty has created a stronger demand for timely insights and data-driven strategies to navigate shifting trade dynamics and economic pressures.

Research Process:

Both primary and secondary data sources have been used in the global RNAi Technology Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/rnai-technology-market

Segment Covered in the RNAi Technology Market:

By Type: Micro RNA, Small interfering RNA, Others.

By Application: Drug discovery and Development, Therapeutics, Drug Delivery, Agriculture, Others.

By End User: Research and Academic Laboratories, Diagnostic Laboratories, Others.

Regional Analysis for RNAi Technology Market:

The regional analysis of the RNAi Technology Market covers key regions including North America, Europe, Asia Pacific Middle East and Africa and South America. The North America with a focus on the U.S., Canada, and Mexico; Europe, highlighting major countries like the U.K., Germany, France, and Italy, along with other nations in the region; Asia-Pacific, covering India, China, Japan, South Korea, and Australia, among others; South America, with emphasis on Colombia, Brazil, and Argentina; and the Middle East & Africa, which includes Saudi Arabia, the U.A.E., South Africa, and other countries. This comprehensive regional breakdown helps identify unique market trends and growth opportunities specific to each area.

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/rnai-technology-market

People Also Ask:

➠ What is the global sales, production, consumption, import, and export value of the RNAi Technology market?

➠ Who are the leading manufacturers in the global RNAi Technology industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?

➠ What opportunities and challenges do vendors in the global RNAi Technology industry face?

➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?

➠ What are the key factors and limitations affecting the growth of the RNAi Technology market?

➠ What are the various sales, marketing, and distribution channels in the global industry?

Browse More Reports: https://www.datamintelligence.com/research-report/rnai-technology-market

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.